Interestingly, patients suffering from CAPS, which is caused by GoF mutations of NLRP3 (under normal conditions NLRP3 is not detectable in keratinocytes [43,106]), do also suffer from—among other symptoms—a skin phenotype [114]. This evidence concerns the gene NLRP3 and cryopyrin-associated periodic syndrome.